Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 2 |
Meta Platforms (Facebook)
META
|
+$742M |
| 3 |
Wells Fargo
WFC
|
+$363M |
| 4 |
Salesforce
CRM
|
+$310M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$869M |
| 2 |
Apple
AAPL
|
+$693M |
| 3 |
PPLI
People Inc
PPLI
|
+$488M |
| 4 |
Expedia Group
EXPE
|
+$409M |
| 5 |
Charter Communications
CHTR
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.04% |
| 2 | Healthcare | 2.79% |
| 3 | Financials | 2.32% |
| 4 | Consumer Discretionary | 2.15% |
| 5 | Industrials | 1.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBIO
6751
PUT
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $622K | ﹤0.01% |
45,700
-35,900
| -44% | -$553K |
|
|
GDVD
6752
DELISTED
Principal Active Global Dividend Income ETF
GDVD
| $622K | ﹤0.01% |
+21,888
| New | +$613K |
|
6753
CALL
First American
FAF
$7.54B
| $621K | ﹤0.01% |
12,200
+8,000
| +190% | +$414K |
|
6754
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.61B
| $621K | ﹤0.01% |
34,838
-3,995
| -10% | -$73.9K |
|
6755
Primis Financial Corp
FRST
$413M
| $621K | ﹤0.01% |
71,513
+145
| +0.2% | +$1.27K |
|
|
VBIV
6756
CALL
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $621K | ﹤0.01% |
7,233
+5,503
| +318% | +$641K |
|
|
TNAV
6757
DELISTED
Telenav Inc.
TNAV
| $621K | ﹤0.01% |
172,526
+124,269
| +258% | +$603K |
|
|
AMAG
6758
CALL
DELISTED
AMAG Pharmaceuticals
AMAG
| $621K | ﹤0.01% |
66,100
+24,000
| +57% | +$228K |
|
6759
PUT
Tucows
TCX
$126M
| $620K | ﹤0.01% |
9,000
-15,700
| -64% | -$1.02M |
|
6760
Columbia Financial
CLBK
$1.23B
| $619K | ﹤0.01% |
55,746
+45,226
| +430% | +$535K |
|
6761
CALL
Dr. Reddy's Laboratories
RDY
$10.2B
| $619K | ﹤0.01% |
44,500
+21,000
| +89% | +$250K |
|
6762
Innovator US Equity Ultra Buffer ETF August
UAUG
$180M
| $619K | ﹤0.01% |
22,912
-55,183
| -71% | -$1.48M |
|
6763
Alphatec Holdings
ATEC
$1.51B
| $618K | ﹤0.01% |
93,014
+36,691
| +65% | +$207K |
|
6764
PUT
Fabrinet
FN
$20.4B
| $618K | ﹤0.01% |
9,800
+700
| +8% | +$47K |
|
6765
State Street SPDR S&P Health Care Services ETF
XHS
$209M
| $618K | ﹤0.01% |
7,985
+2,892
| +57% | +$217K |
|
6766
PUT
Antero Midstream
AM
$10.7B
| $617K | ﹤0.01% |
114,900
-21,600
| -16% | -$132K |
|
|
EVOK
6767
CALL
DELISTED
Evoke Pharma
EVOK
| $617K | ﹤0.01% |
+913
| New | +$582K |
|
6768
PUT
Monro
MNRO
$359M
| $617K | ﹤0.01% |
15,200
+7,500
| +97% | +$383K |
|
6769
PUT
Invesco DB Oil Fund
DBO
$391M
| $616K | ﹤0.01% |
85,700
-5,400
| -6% | -$39.8K |
|
6770
Regional Management Corp
RM
$309M
| $616K | ﹤0.01% |
36,931
-19,732
| -35% | -$339K |
|
|
SRNE
6771
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $616K | ﹤0.01% |
55,278
-364,991
| -87% | -$3.34M |
|
6772
InfuSystem Holdings
INFU
$244M
| $615K | ﹤0.01% |
47,971
+35,453
| +283% | +$461K |
|
6773
PUT
Medpace
MEDP
$16.1B
| $615K | ﹤0.01% |
5,500
-9,100
| -62% | -$1.05M |
|
6774
Prudential
PUK
$34.7B
| $615K | ﹤0.01% |
22,176
+10,179
| +85% | +$305K |
|
6775
Rhythm Pharmaceuticals
RYTM
$7.95B
| $615K | ﹤0.01% |
+28,398
| New | +$651K |
|
Similar funds
Ken Griffin's Q3 2020 Portfolio in Review
As of Q3 2020, Ken Griffin held 11,253 positions worth $353B, up 26% from $280B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Ken Griffin deployed $24.6B of net new capital in Q3 2020, opening 1,597 new positions and adding to 4,071 existing holdings. Its largest new stake was iShares MSCI EAFE ETF: 4,016,602 shares worth $256M.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Amazon, an estimated $869M trimmed.
- Ken Griffin's largest Q3 2020 buy was iShares MSCI EAFE ETF: 4,016,602 shares worth $256M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $1.04B increase.
- Ken Griffin's biggest Q3 2020 reduction was Amazon, cutting an estimated $869M.
- Ken Griffin fully exited Intel in Q3 2020, selling an estimated $249M.
- Ken Griffin's ten largest holdings make up 36% of its $353B portfolio in Q3 2020.
- Ken Griffin opened 1,597 new positions and closed 1,263 in Q3 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $353B.
Based on Citadel Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.